Prenumeration
STENOCARE announced on June 17th that the company is planning an expansion into Canada together with North America industry experts, which means that STENOCARE will bring the company’s flagship suite of products to the Canadian market, which is a vast market with an annual revenue of approximately CAD 5bn. STENOCARE are currently exploring different models and sales channels to enter the market with the aim is to sign a commercial agreement in H2-24.
Read Analyst Group’s comment on the press release here
Read more about our view of STENOCARE and the ongoing exercise of warrants here
About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of an comment on STENOCARE. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.